The AMD Center

Filter Your Results




Maintaining Perspective in Wet AMD Therapy

Allen C. Ho, MD; and Robert L. Avery, MD

May/June 2019— Treating age-related macular degeneration (AMD) ranks among the noblest work of a retina subspecialist. Practically, AMD

Emerging Treatments for Neovascular AMD

Natalie Huang, MD; and Patrick Oellers, MD

May/June 2019—Novel treatment options hold the promise of longer-term VEGF suppression.

Gene Therapy Trials for Wet Age-Related Macular Degeneration

Allen C. Ho, MD; and Robert L. Avery, MD

May/June 2019—After a series of failed trials, hope is on the horizon for the viability of gene therapy for wet AMD.

Sustained Suppression of VEGF: Looking Forward and Looking Back

Peter A. Campochiaro, MD

May/June 2019—The results of the LADDER trial demonstrate a major step forward but introduce many questions.

Patients Lost to Follow-Up: AMD and Anti-VEGF Therapy

Anthony Obeid, MD, MPH; and Jason Hsu, MD

May/June 2019—A new study calculates the rates of and risk factors for losing patients to follow-up after receiving anti-VEGF therapy for AMD.

Use of the Port Delivery System in AMD

Samir N. Patel, MD; Thomas L. Jenkins, MD; Dante J. Pieramici, MD; and Carl D. Regillo, MD

May/June 2019—An update and review of this novel approach to anti-VEGF drug delivery.

Retina News

October 2018—Apellis Begins PHASE 3 Trials FOR COMPLEMENT INHIBITION in GA Two phase 3 trials of a complement-inhibiting peptide have begun, assessing the safety and efficacy of the com…

The Role of Surgery in Managing Severe Complications of Neovascular AMD

Emiliano Di Carlo, MD; and Albert J. Augustin, MD

September 2018—Some patients who do not respond to anti-VEGF therapy may benefit from surgical intervention.


This Month's Supplements


Contact Info

Bryn Mawr Communications LLC
1008 Upper Gulph Road, Suite 200
Wayne, PA 19087

Phone: 484-581-1800
Fax: 484-581-1818

Scott Krzywonos

Janet Burk

About Retina Today

Retina Today is a publication that delivers the latest research and clinical developments from areas such as medical retina, retinal surgery, vitreous, diabetes, retinal imaging, posterior segment oncology and ocular trauma. Each issue provides insight from well-respected specialists on cutting-edge therapies and surgical techniques that are currently in use and on the horizon.